Xeris Biopharma Holdings (NASDAQ:XERS) reported its Q4 earnings results on Thursday, March 10, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Earnings
Xeris Biopharma Holdings missed estimated earnings by 75.0%, reporting an EPS of $-0.42 versus an estimate of $-0.24.
Revenue was up $14.34 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 9.47% increase in the share price the next day.
Here's a look at Xeris Biopharma Holdings's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.37 | -0.30 | -0.34 | -0.38 |
| EPS Actual | -0.39 | -0.41 | -0.30 | -0.41 |
| Revenue Estimate | 11.03M | 9.54M | 7.47M | 8.21M |
| Revenue Actual | 11.04M | 8.84M | 8.05M | 7.09M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
